A detailed history of Greatmark Investment Partners, Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Greatmark Investment Partners, Inc. holds 2,372 shares of LLY stock, worth $1.87 Million. This represents 0.29% of its overall portfolio holdings.

Number of Shares
2,372
Previous 2,372 -0.0%
Holding current value
$1.87 Million
Previous $2.15 Million 2.14%
% of portfolio
0.29%
Previous 0.31%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 08, 2024

SELL
$724.87 - $909.04 $10,873 - $13,635
-15 Reduced 0.63%
2,372 $2.15 Million
Q1 2024

May 09, 2024

BUY
$592.2 - $792.28 $37,900 - $50,705
64 Added 2.76%
2,387 $1.86 Million
Q4 2023

Feb 05, 2024

BUY
$525.19 - $619.13 $525 - $619
1 Added 0.04%
2,323 $1.35 Million
Q3 2023

Nov 08, 2023

SELL
$434.7 - $599.3 $2,173 - $2,996
-5 Reduced 0.21%
2,322 $1.25 Million
Q2 2023

Aug 02, 2023

SELL
$350.74 - $468.98 $63,133 - $84,416
-180 Reduced 7.18%
2,327 $1.09 Million
Q4 2020

Feb 08, 2021

SELL
$130.46 - $172.63 $3,261 - $4,315
-25 Reduced 0.99%
2,507 $423,000
Q3 2020

Oct 28, 2020

SELL
$146.22 - $169.13 $10,966 - $12,684
-75 Reduced 2.88%
2,532 $375,000
Q2 2020

Aug 04, 2020

SELL
$136.42 - $164.18 $27,283 - $32,836
-200 Reduced 7.13%
2,607 $428,000
Q1 2020

Apr 29, 2020

SELL
$119.05 - $147.35 $11,905 - $14,735
-100 Reduced 3.44%
2,807 $389,000
Q2 2018

Aug 03, 2018

BUY
$75.7 - $86.88 $15,140 - $17,376
200 Added 7.39%
2,907 $248,000
Q1 2018

May 04, 2018

SELL
$74.21 - $87.6 $74,210 - $87,600
-1,000 Reduced 26.98%
2,707 $209,000
Q3 2017

Nov 02, 2017

BUY
$77.07 - $85.54 $285,698 - $317,096
3,707
3,707 $317,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $749B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Greatmark Investment Partners, Inc. Portfolio

Follow Greatmark Investment Partners, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Greatmark Investment Partners, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Greatmark Investment Partners, Inc. with notifications on news.